Prognosis and prediction of antibiotic benefit in adults with clinically diagnosed acute rhinosinusitis: an individual participant data meta-analysis
Prognosis and prediction of antibiotic benefit in adults with clinically diagnosed acute rhinosinusitis: an individual participant data meta-analysis
Background: a previous individual participant data meta-analysis (IPD-MA) of antibiotics for adults with clinically diagnosed acute rhinosinusitis (ARS) showed a marginal overall effect of antibiotics, but was unable to identify patients that are most likely to benefit from antibiotics when applying conventional (i.e. univariable or one-variable-at-a-time) subgroup analysis. We updated the systematic review and investigated whether multivariable prediction of patient-level prognosis and antibiotic treatment effect may lead to more tailored treatment assignment in adults presenting to primary care with ARS.
Methods: an IPD-MA of nine double-blind placebo-controlled trials of antibiotic treatment (n=2539) was conducted, with the probability of being cured at 8–15 days as the primary outcome. A logistic mixed effects model was developed to predict the probability of being cured based on demographic characteristics, signs and symptoms, and antibiotic treatment assignment. Predictive performance was quantified based on internal-external cross-validation in terms of calibration and discrimination performance, overall model fit, and the accuracy of individual predictions.
Results: results indicate that the prognosis with respect to risk of cure could not be reliably predicted (c-statistic 0.58 and Brier score 0.24). Similarly, patient-level treatment effect predictions did not reliably distinguish between those that did and did not benefit from antibiotics (c-for-benefit 0.50).
Conclusions: in conclusion, multivariable prediction based on patient demographics and common signs and symptoms did not reliably predict the patient-level probability of cure and antibiotic effect in this IPD-MA. Therefore, these characteristics cannot be expected to reliably distinguish those that do and do not benefit from antibiotics in adults presenting to primary care with ARS.
16
Hoogland, Jeroen
1d0d384c-6250-4b81-938c-022adeb943fa
Takada, Toshihiko
ee6bcc2b-65ec-45b7-a5bd-1c74faf16d8a
van Smeden, Maarten
9d821332-2c57-457b-9619-d7e21a2df7d9
Rovers, Maroeska M.
19abaefc-4ba6-4b54-a0f3-5ba7d305e28b
de Sutter, An I.
d4e66818-3c64-4049-a1ad-fc81356bd3e8
Merenstein, Daniel
b23e156f-f975-440e-b928-577f5793408d
Kaiser, Laurent
fb7b1dca-2e26-41ff-8bf0-12374ba50e22
Liira, Helena
fa0fc846-d9dd-4cee-a21a-a292b0ed9dd2
Little, Paul
1bf2d1f7-200c-47a5-ab16-fe5a8756a777
Bucher, Heiner C.
e38c2e7f-86af-4ecd-a798-e9510ce9a599
Moons, Karel G.M.
2ab0cb89-1666-46d1-8716-80f55eae539a
Reitsma, Johannes B.
2b18f989-5b73-4fc4-b602-d63d0d17b37e
Venekamp, Roderick P.
04309a42-770e-425b-9bc3-85930ca3bcc2
5 September 2023
Hoogland, Jeroen
1d0d384c-6250-4b81-938c-022adeb943fa
Takada, Toshihiko
ee6bcc2b-65ec-45b7-a5bd-1c74faf16d8a
van Smeden, Maarten
9d821332-2c57-457b-9619-d7e21a2df7d9
Rovers, Maroeska M.
19abaefc-4ba6-4b54-a0f3-5ba7d305e28b
de Sutter, An I.
d4e66818-3c64-4049-a1ad-fc81356bd3e8
Merenstein, Daniel
b23e156f-f975-440e-b928-577f5793408d
Kaiser, Laurent
fb7b1dca-2e26-41ff-8bf0-12374ba50e22
Liira, Helena
fa0fc846-d9dd-4cee-a21a-a292b0ed9dd2
Little, Paul
1bf2d1f7-200c-47a5-ab16-fe5a8756a777
Bucher, Heiner C.
e38c2e7f-86af-4ecd-a798-e9510ce9a599
Moons, Karel G.M.
2ab0cb89-1666-46d1-8716-80f55eae539a
Reitsma, Johannes B.
2b18f989-5b73-4fc4-b602-d63d0d17b37e
Venekamp, Roderick P.
04309a42-770e-425b-9bc3-85930ca3bcc2
Hoogland, Jeroen, Takada, Toshihiko, van Smeden, Maarten, Rovers, Maroeska M., de Sutter, An I., Merenstein, Daniel, Kaiser, Laurent, Liira, Helena, Little, Paul, Bucher, Heiner C., Moons, Karel G.M., Reitsma, Johannes B. and Venekamp, Roderick P.
(2023)
Prognosis and prediction of antibiotic benefit in adults with clinically diagnosed acute rhinosinusitis: an individual participant data meta-analysis.
Diagnostic and Prognostic Research, 7 (1), , [16].
(doi:10.1186/s41512-023-00154-0).
Abstract
Background: a previous individual participant data meta-analysis (IPD-MA) of antibiotics for adults with clinically diagnosed acute rhinosinusitis (ARS) showed a marginal overall effect of antibiotics, but was unable to identify patients that are most likely to benefit from antibiotics when applying conventional (i.e. univariable or one-variable-at-a-time) subgroup analysis. We updated the systematic review and investigated whether multivariable prediction of patient-level prognosis and antibiotic treatment effect may lead to more tailored treatment assignment in adults presenting to primary care with ARS.
Methods: an IPD-MA of nine double-blind placebo-controlled trials of antibiotic treatment (n=2539) was conducted, with the probability of being cured at 8–15 days as the primary outcome. A logistic mixed effects model was developed to predict the probability of being cured based on demographic characteristics, signs and symptoms, and antibiotic treatment assignment. Predictive performance was quantified based on internal-external cross-validation in terms of calibration and discrimination performance, overall model fit, and the accuracy of individual predictions.
Results: results indicate that the prognosis with respect to risk of cure could not be reliably predicted (c-statistic 0.58 and Brier score 0.24). Similarly, patient-level treatment effect predictions did not reliably distinguish between those that did and did not benefit from antibiotics (c-for-benefit 0.50).
Conclusions: in conclusion, multivariable prediction based on patient demographics and common signs and symptoms did not reliably predict the patient-level probability of cure and antibiotic effect in this IPD-MA. Therefore, these characteristics cannot be expected to reliably distinguish those that do and do not benefit from antibiotics in adults presenting to primary care with ARS.
Text
s41512-023-00154-0
- Version of Record
More information
Accepted/In Press date: 20 July 2023
Published date: 5 September 2023
Additional Information:
© 2023. BioMed Central Ltd., part of Springer Nature.
Identifiers
Local EPrints ID: 485954
URI: http://eprints.soton.ac.uk/id/eprint/485954
PURE UUID: 2377d152-0e6f-42b2-b928-9111b8185fc1
Catalogue record
Date deposited: 04 Jan 2024 06:00
Last modified: 12 Jul 2024 01:35
Export record
Altmetrics
Contributors
Author:
Jeroen Hoogland
Author:
Toshihiko Takada
Author:
Maarten van Smeden
Author:
Maroeska M. Rovers
Author:
An I. de Sutter
Author:
Daniel Merenstein
Author:
Laurent Kaiser
Author:
Helena Liira
Author:
Heiner C. Bucher
Author:
Karel G.M. Moons
Author:
Johannes B. Reitsma
Author:
Roderick P. Venekamp
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics